Introduction {#s1}
============

Intrauterine and postpartum infections remain an important cause of morbidity and mortality worldwide. One of the bacterial species commonly responsible for these infections is *Streptococcus agalactiae*, also known as group B *Streptococcus* (GBS). GBS colonizes the urogenital or gastrointestinal tract of about 10%--30% of humans, depending on gender, geographical origin, ethnicity, and screening method used (for a review see [@pone.0006114-Shet1] and references therein). In recent decades GBS has become an important human pathogen [@pone.0006114-Phares1], now responsible for a large percentage of female urogenital tract infections in non-pregnant women and amnionitis and septic abortion in pregnant individuals [@pone.0006114-Farley1], [@pone.0006114-Schuchat1]. GBS also is a major cause of fatal septicemia and meningitis in newborns and invasive infections in elderly and people with underlying diseases [@pone.0006114-Farley1], [@pone.0006114-Schuchat1]. Recent studies [@pone.0006114-Sitkiewicz1], [@pone.0006114-Mereghetti1], [@pone.0006114-Mereghetti2] have shown that the transcriptome of GBS responds extensively to environmental changes, therefore we hypothesized that this organism will significantly remodel its global transcript profile in response to growth in human amniotic fluid. In this study, we employed an *ex vivo* strategy to characterize the global transcriptome response of GBS when grown in human amniotic fluid. The *ex vivo* strategy has been successfully used to study adaptation of pathogenic bacteria to multiple environments of the human body such as blood and saliva [@pone.0006114-Mereghetti2], [@pone.0006114-Graham1], [@pone.0006114-Shelburne1]. To gain significant new information about the interaction of GBS with amniotic fluid over time, we conducted expression microarray analysis at three time points throughout the pathogen growth cycle.

Materials and Methods {#s2}
=====================

Bacterial strains and routine growth {#s2a}
------------------------------------

Serotype III GBS strain NEM316 was used in these studies because the genome has been sequenced, the organism has been used in many pathogenesis studies, and serotype III organisms cause a large number of serious human infections [@pone.0006114-Glaser1]. The strain was grown in Todd Hewitt medium with 0.5% yeast extract (THY) or on Trypticase Soy agar (TSA) II plates supplemented with 5% sheep blood (BD Diagnostics) at 37° in a 5% CO~2~ atmosphere.

Growth of GBS in human amniotic fluid {#s2b}
-------------------------------------

Human amniotic fluid (AF) was collected from pregnant women seen at The Methodist Hospital, Houston, Texas, or Weill Medical College of Cornell University in New York City. Samples were collected in accordance with an exempt human subjects protocol approved by the Institution Review Board of each institution. The study involved collection of existing diagnostic specimens routinely collected during clinical procedures as amniocenteses and would have been otherwise discarded. Specimens were stripped of all identifiers and processed in a manner that subjects cannot be directly or indirectly identified.

After collection, each specimen was centrifuged to remove host cells, filter sterilized, and frozen at −20°C. After thawing, each AF sample was tested to determine if it supported growth of GBS. Aliquots (250 µl) of heat inactivated (95° for 5 min) AF were inoculated with GBS prepared as follows. Bacteria from overnight cultures grown in THY were collected by centrifugation, washed twice with sterile PBS, and suspended in PBS. 10 µl of 100× bacteria diluted further in PBS were used to inoculate each 250 µl sample of AF (resulting in a final inoculum of ∼10^4^ CFU/ml) and were incubated at 37°C, in 5% CO~2~ for 24 h. To avoid artifacts caused by carryover of THY medium, after 24 h of growth in AF (designated AF1), the GBS were diluted 1∶500 into a fresh aliquot of AF (designated AF2). Growth of GBS in AF2 was quantified every hour for first 12 h and thereafter every 12 h by plating serial dilutions on TSA II plates (BD Diagnostics). For transcriptome studies, AF samples were pooled and three independent AF2 cultures were inoculated with GBS (biological replicates). Bacteria were collected by centrifugation at time points corresponding to the mid-logarithmic (ML), late-logarithmic/early stationary (LL) and stationary (S) phase of growth ([Fig. 1](#pone-0006114-g001){ref-type="fig"}).

![Growth of GBS in THY and AF.\
Growth of GBS in THY laboratory medium (blue) and human AF (red). Arrows mark time points of sample collection for RNA isolation. Blue arrows denote points for samples collected during growth in THY, and red arrows denote collection points for bacteria grown in AF. ML, mid-logarithmic growth phase, LL; late-logarithmic growth phase, ES; early stationary growth phase; and S, stationary growth phase.](pone.0006114.g001){#pone-0006114-g001}

Cultures grown in THY medium were prepared as described previously [@pone.0006114-Sitkiewicz1]. Briefly, three independent cultures of GBS were grown in the same lot of THY broth and GBS cells were harvested at three time points corresponding to mid-logarithmic (ML), late log/early stationary (ES), and stationary (S) growth phase ([Fig. 1](#pone-0006114-g001){ref-type="fig"}).

RNA isolation and processing {#s2c}
----------------------------

The bacterial aliquots used for RNA isolation were mixed with 2 volumes of RNA Protect reagent (Qiagen), and the cells were collected by centrifugation and stored at −80°C. RNA was isolated using a modified TRIZOL (Invitrogen) method [@pone.0006114-Chomczynski1]. Briefly, GBS pellets were suspended in 200 µl of Max Bacterial Enhancement Reagent (Invitrogen), incubated according to the manufacturer\'s recommendations, mixed with 1 ml of TRIZOL, and disrupted using lysis matrix B (MP Biochemicals). Cell debris was removed by centrifugation, and RNA was extracted with chloroform and precipitated with isopropanol. The precipitated RNA was suspended in 100 µl of RNAse free water (Ambion, Austin TX) and further purified using RNeasy 96 well plates. All samples were processed simultaneously to minimize experimental variation. Reverse transcription, cDNA fragmentation, and labeling was performed as described previously [@pone.0006114-Sitkiewicz2].

Microarray analysis {#s2d}
-------------------

Microarray analysis was performed using a custom-made Affymetrix chip that contained 1,994 probe sets, representing the annotated ORFs of GBS strain NEM316 [@pone.0006114-Shelburne2]. Chip hybridization data were acquired using Affymetrix GeneChip Operating Software (GCOS 1.4) and normalized to allow multi-condition comparison. GCOS-acquired hybridization intensity values were normalized to the total intensity of all GBS genes present on the chip. Individual intensity for the gene transcripts generated by GCOS was divided by the sum of all intensities of the GBS hybridizing probes. Normalized hybridization values were used in all subsequent analysis. Data derived from three biological replicates obtained from three independent cultures were used to calculate mean values. PartekPro (Partek) and Array Assist (Stratagene) software were used to assess chip quality and chip-to-chip variability, and for data mining and visualization. Average normalized hybridization values were used to calculate AF/THY transcript ratios. Average values generated after hybridization of samples from AF_ML phase were divided by values generated from samples THY_ML to generate mid-logarithmic AF/THY ratios (ML). Average values from samples AF_LL were divided by values generated from samples THY_ES to generate late-logarithmic AF/THY ratios (LL). Average values from samples AF_S were divided by values generated from samples THY_S to generate stationary-phase AF/THY ratios (S). Only AF/THY ratios above a 2-fold change and with a P value less than 0.05 were included in the functional analysis. Normalized hybridization values are deposited in GEO database (<http://www.ncbi.nlm.nih.gov/geo/>) under GSE14456 and GSE12238 accession numbers.

Results and Discussion {#s3}
======================

Characterization of GBS growth in AF {#s3a}
------------------------------------

Prior to characterizing the transcriptome of GBS grown in human AF, we studied the growth of strain NEM316 in THY medium. GBS grew rapidly in this medium, with a generation time of ∼35 min in logarithmic phase ([Fig. 1](#pone-0006114-g001){ref-type="fig"}). The bacterial density reached ∼10^9^ CFUs/ml in the stationary phase ([Fig. 1](#pone-0006114-g001){ref-type="fig"}). We next analyzed the growth of strain NEM316 in human AF. AF has been reported to have antimicrobial properties toward various species of bacteria due to β-lysin and lysozyme activity, which depends on divalent cations such as zinc and phosphate [@pone.0006114-Scane1], [@pone.0006114-Scane2]. In multiple studies reported in the literature 18--73% of AF samples exhibited inhibitory properties towards various bacterial species. The antimicrobial properties depend on gestation stage and ethnicity [@pone.0006114-Larsen1], [@pone.0006114-Mathai1], [@pone.0006114-Nazir1], [@pone.0006114-Hagio1], [@pone.0006114-Appelbaum1]. Because individual specimens of AF can vary in their antimicrobial properties even towards GBS [@pone.0006114-Evans1], we first tested the ability of the collected samples to support GBS growth. Consistent with the majority of the data reported in the literature, none of the AF specimens significantly inhibit the growth of strain NEM316 (data not shown). To avoid the effects of sample-to-sample variability, pooled AF was used in all subsequent experiments. Growth of GBS in AF is comparable with growth in THY with respect to cell density (∼10^9^ CFU/ml) and growth rate in exponential phase ([Fig. 1](#pone-0006114-g001){ref-type="fig"}).

Expression microarray analysis: quantitative differences during growth and in response to AF {#s3b}
--------------------------------------------------------------------------------------------

To characterize the transcriptome of GBS grown in AF, we used an *ex vivo* expression microarray analysis strategy that we previously employed to study transcription interactions of streptococci with body fluids such as blood and saliva [@pone.0006114-Mereghetti2], [@pone.0006114-Graham1], [@pone.0006114-Shelburne1]. Strain NEM316 was grown in THY broth or pooled AF and harvested at various time points ([Fig. 1](#pone-0006114-g001){ref-type="fig"}). After transcriptome data acquisition, we assessed chip-to-chip data variability and quality using principal component analysis (PCA) ([Fig. 2](#pone-0006114-g002){ref-type="fig"}). The PCA analysis discriminated very well between the transcript data from the chips representing the various growth phases studied ([Fig. 2](#pone-0006114-g002){ref-type="fig"}). These results indicated that the transcriptome profile data from triplicate experiments were highly reproducible and of sufficient quality to permit robust statistical analysis and interpretation. The data clearly show that the transcriptome of GBS strain NEM316 is considerably remodelled in a growth-phase and growth medium-specific fashion. During growth of GBS in either THY [@pone.0006114-Sitkiewicz1] or AF (this work), we observed over 70% of all transcripts ([table S1](#pone.0006114.s001){ref-type="supplementary-material"}) exhibiting differential expression during at least one experimental growth phase what is a sign of great transcriptome plasticity in response to environment changing over time. Interestingly the biggest differences between expression in AF and THY are observed during transition from logarithmic to stationary phase (LL) ([Fig. 3](#pone-0006114-g003){ref-type="fig"}) and as many as 54% of all GBS transcripts present on the array are differentially expressed.

![PCA plot analysis of microarray data.\
Each circle represents a single biological replicate. Each experimental condition is designated with a separate color. Distinct clusters of three replicates denote highly reproducible arrays. ML, mid-logarithmic growth phase, LL; late-logarithmic growth phase, ES; early stationary growth phase; and S, stationary growth phase.](pone.0006114.g002){#pone-0006114-g002}

![Quantitative differences in gene expression between THY and AF.\
Genes regarded as differentially expressed have an AF/THY transcript level ratio of 2 and above (better expressed in AF) or 0.5 and below (better expressed in THY). Arrow up, number of genes better expressed in AF; arrow down, number of genes better expressed in THY. ML, mid-logarithmic growth phase, LL; late-logarithmic growth phase, ES; early stationary growth phase; and S, stationary growth phase.](pone.0006114.g003){#pone-0006114-g003}

We next used a scatter plot analysis ([Fig. 4](#pone-0006114-g004){ref-type="fig"}) to compare the dynamics of transcript expression in ML, LL, and S phase between strain NEM316 grown in AF and THY. In the ML phase, transcript changes were rather modest, comparing with changes in LL and S phases, with AF/THY ratios rarely exceeding 10-fold. In the ML and LL phase transcripts are shifted toward THY, with a smaller number of transcripts expressed better in AF. In the S phase of growth, the general level of transcription is lower (note shift of spots towards left bottom corner, [Fig. 4](#pone-0006114-g004){ref-type="fig"}) than in ML and LL phase. However, the number of genes up regulated in AF is higher than in other phases of growth.

![Dynamics of gene expression between THY and AF at various stages of growth.\
The location of each dot represents a single transcript. Dotted lines denote two-fold difference between transcript level in AF and THY, thick lines denote ten-fold difference in expression between AF and THY. Each panel represents differences in expression in mid-logarithmic (ML), late-logarithmic (LL) and stationary (S) growth phases. *x*-axis, expression level in THY; *y*-axis, expression level in AF.](pone.0006114.g004){#pone-0006114-g004}

For ease of analysis and description, we assigned the GBS genes to functional categories based on their annotation and presumed involvement in metabolic processes or cell maintenance functions ([Tables 1](#pone-0006114-t001){ref-type="table"}, [2](#pone-0006114-t002){ref-type="table"}, [3](#pone-0006114-t003){ref-type="table"}, [4](#pone-0006114-t004){ref-type="table"}, [5](#pone-0006114-t005){ref-type="table"}, [6](#pone-0006114-t006){ref-type="table"} and [Table S1](#pone.0006114.s001){ref-type="supplementary-material"}). In general, the transcript levels of most genes in each functional category were better expressed during growth in THY. However, the transcripts of genes belonging to several functional categories, including amino acid, carbohydrate, and nucleotide metabolism were higher in AF at one or more growth points ([Fig. 5A](#pone-0006114-g005){ref-type="fig"}).

![Functional dynamics of transcriptional changes between gene expression in THY and AF.\
A. Bar graphs present the number of genes better expressed in THY or AF in three of the most prominently changed metabolic categories. B. Major metabolic trends in nutrient acquisition. Red symbolizes genes better expressed in AF, green better expressed in THY.](pone.0006114.g005){#pone-0006114-g005}

10.1371/journal.pone.0006114.t001

###### Selected genes involved in stress response regulated in response to amniotic fluid.

![](pone.0006114.t001){#pone-0006114-t001-1}

  Locus      Name       ML         LL           S                          Putative function
  --------- ------- ---------- ----------- ----------- ----------------------------------------------------------
  gbs0009                       **−7.2**                                 Heat shock protein 15
  gbs0015    ftsH               **−9.0**    **−4.5**            Cell division protein ftsH (EC 3.4.24.-)
  gbs0095    grpE               **−3.7**                                      GrpE protein
  gbs0097    dnaJ                           **−6.3**                       chaperone protein
  gbs0104     tig               **−5.3**                          Trigger factor, ppiase (EC 5.2.1.8)
  gbs0109    radA               **−8.5**    **−2.4**                    DNA repair protein RadA
  gbs0222     \-                 **3.2**    **−3.1**                 DNA-damage-inducible protein J
  gbs0284     \-                **−2.3**                           Thioredoxin reductase (EC 1.8.1.9)
  gbs0289    recU               **−14.7**   **−2.8**                   Recombination protein recU
  gbs0447    recX               **−6.3**                                Regulatory protein recX
  gbs0502                       **−5.0**                     ATP-dependent endopeptidase Lon (EC 3.4.21.53)
  gbs0547    recN               **−2.4**                                DNA repair protein recN
  gbs0786    recR               **−2.1**     **4.3**                   Recombination protein recR
  gbs0838    nrdH               **−5.6**                                      Glutaredoxin
  gbs1202     \-     **−2.4**                                     General stress protein, Gls24 family
  gbs1257                       **−2.6**                        Endopeptidase, M10 family (EC 3.4.24.-)
  gbs1376    clpL    **−3.3**                **5.2**    ATP-dependent endopeptidase clp ATP-binding subunit clpL
  gbs1383    clpX               **−3.9**                ATP-dependent endopeptidase clp ATP-binding subunit clpX
  gbs1423    trxB               **−2.6**                           Thioredoxin reductase (EC 1.8.1.9)
  gbs1586                       **−3.6**                    Peptidyl-prolyl cis-trans isomerase (EC 5.2.1.8)
  gbs1674     \-                 **2.4**     **2.9**                Endopeptidase htpX (EC 3.4.24.-)
  gbs1721     \-     **−2.3**    **2.2**                            Universal stress protein family
  gbs1738     \-     **−2.1**               **−2.4**              General stress protein, Gls24 family
  gbs1764    mutS2              **−2.8**                            DNA mismatch repair protein mutS
  gbs1778                       **−14.2**   **−27.0**               Universal stress protein family
  gbs1865    hslO               **−8.0**                                   33 kDa chaperonin
  gbs2029    groEL               **2.2**                                60 kDa chaperonin GROEL
  gbs2048    cinA                            **2.3**            competence/damage-inducible protein CinA
  gbs2052    mutL               **−2.4**                            DNA mismatch repair protein mutL
  gbs2053     csp               **−55.0**   **−6.0**                       Cold shock protein
  gbs2054    mutS               **−3.1**                            DNA mismatch repair protein mutS
  gbs2113     \-                **−4.8**                     Non-proteolytic protein, peptidase family M16
  gbs2115    recF               **−4.9**                        DNA replication and repair protein recF

Values represent fold change in expression in amniotic fluid compared to expression in THY; ML, mid-logarithmic growth phase; LL, late-logarithmic growth phase; S, stationary growth phase; cut-off two fold change with P value less than 0.05. Positive values represent genes up-regulated in AF, negative values represent down-regulated (better expressed in THY) genes. Full list of changes is published as [Table S1](#pone.0006114.s001){ref-type="supplementary-material"}.

10.1371/journal.pone.0006114.t002

###### Selected regulators differentially expressed in response to AF.

![](pone.0006114.t002){#pone-0006114-t002-2}

  Locus       Name       ML         LL           S                                Putative function
  --------- -------- ---------- ----------- ----------- ----------------------------------------------------------------------
  gbs0094     hrcA               **−2.2**                            Heat-inducible transcription repressor hrcA
  gbs0105     rpoE               **−17.7**                       DNA-directed RNA polymerase delta chain (EC 2.7.7.6)
  gbs0118      \-     **−5.8**                                                 Ribose operon repressor
  gbs0121                        **−2.3**    **−2.6**                      Two-component response regulator
  gbs0135     mecA               **−7.9**                           Negative regulator of genetic competence mecA
  gbs0156     rpoB               **−3.9**                        DNA-directed RNA polymerase beta chain (EC 2.7.7.6)
  gbs0181      \-                **−3.9**                                    Autolysin response regulator
  gbs0248      \-     **−2.3**   **−4.4**                              ECF-type sigma factor negative effector
  gbs0249      \-     **−3.4**   **−17.4**                               RNA polymerase ECF-type sigma factor
  gbs0299                        **−4.4**                                  Two-component response regulator
  gbs0302      \-                **−9.2**                        DNA-directed RNA polymerase omega chain (EC 2.7.7.6)
  gbs0414     nusA                           **−2.6**                    transcription elongation factor NusA
  gbs0427     perR               **−2.9**                              Oxidative stress response regulator BosR
  gbs0429             **−2.0**   **−2.9**                               Two-component response regulator SaeR
  gbs0546    argR1               **−4.0**    **−2.6**                          Arginine repressor, argR
  gbs0680     ccpA                           **−4.4**                        catabolite control protein A
  gbs0741     vicR               **−2.2**                               Two-component response regulator VicR
  gbs0756                        **−2.6**                          Stress-responsive transcriptional regulator PspC
  gbs0804                        **−3.5**                                    Catabolite control protein B
  gbs1050      \-     **4.4**     **4.2**    **13.3**                        Carbon starvation protein A
  gbs1398      \-     **−2.2**   **−6.8**                                  Two-component response regulator
  gbs1496     rpoD               **−2.1**    **−2.8**                      RNA polymerase sigma factor rpoD
  gbs1530     rofA                           **−5.3**                         transcriptional regulator
  gbs1672     covR               **−2.3**                                      Response regulator CsrR
  gbs1719     codY               **−11.0**                             Transcription pleiotropic repressor codY
  gbs1736     scrR    **−4.3**                                                 Sucrose operon repressor
  gbs1835                        **−2.6**    **−3.1**                     Transcriptional regulatory protein
  gbs1870     ctsR               **−4.7**                                   Transcriptional regulator ctsR
  gbs1882      \-                **−2.4**                                     Catabolite gene activator
  gbs1909     dpiA               **−4.6**    **−18.6**                    Transcriptional regulatory protein
  gbs1934      \-     **−2.7**   **−20.4**   **−13.4**                  Two-component response regulator yesN
  gbs1944     fasA    **2.0**                                                  Response regulator FasA
  gbs1948                        **−2.6**                Alkaline phosphatase synthesis two-component response regulator phoP
  gbs2055    argR2               **−4.0**                                      Arginine repressor, argR
  gbs2081                        **−2.3**                                 Transcriptional regulatory protein
  gbs2087             **−3.8**   **−6.9**    **−10.8**                     Two-component response regulator
  gbs2119    ahrC.2              **−8.3**    **−3.3**                          Arginine repressor, argR

Values represent fold change in expression in amniotic fluid in comparison with expression in THY. Positive values represent genes up-regulated in AF, negative values represent down-regulated (better expressed in THY) genes. ML, mid-logarithmic growth phase; LL, late-logarithmic growth phase; S, stationary growth phase; cut-off: fold change above 2 and P value less than 0.05. Full list of changes is published as [Table S1](#pone.0006114.s001){ref-type="supplementary-material"}.

10.1371/journal.pone.0006114.t003

###### Selected genes involved in pathogenesis up- or down-regulated (better expressed in THY) in response to amniotic fluid.

![](pone.0006114.t003){#pone-0006114-t003-3}

  Locus         Name       ML         LL           S       Region                    Putative function
  ----------- -------- ---------- ----------- ----------- -------- ------------------------------------------------------
  gbs0031                          **−6.9**                                           Surface antigen
  gbs0393               **−3.5**   **−4.2**    **−3.2**                             Hypothetical protein
  gbs0451               **3.2**    **−2.6**                                       C5A peptidase precursor
  gbs0470       alp2    **−2.3**               **−2.8**                             Cell surface protein
  gbs0631                                       **2.9**                                   Sortase
  gbs0644       cylX                **4.6**                  H                      Hypothetical protein
  gbs0645       cylD    **2.6**     **5.5**                  H                    Malonyl-CoA-transacylase
  gbs0646       cylG    **3.7**     **6.8**                  H                      3-oxoacyl-reductase
  gbs0647       acpC    **3.9**     **4.3**                  H                      Acyl carrier protein
  gbs0648               **2.7**     **4.0**                  H               (3R)-hydroxymyristoyl-dehydratase
  gbs0649       cylA    **2.8**     **4.2**                  H                      ATP-binding protein
  gbs0650       cylB    **3.6**     **2.5**                  H                            Permease
  gbs0651       cylE    **3.4**     **2.3**                  H                      Hypothetical protein
  gbs0652       cylF    **3.8**     **2.4**                  H                     Aminomethyltransferase
  gbs0653       cylI    **4.0**     **2.3**                  H                       3-oxoacyl synthase
  gbs0654       cylJ    **3.9**     **2.2**                  H                    UDP glycosyltransferase
  gbs0655       cylK    **2.7**     **2.1**    **−2.5**      H                      Hypothetical protein
  gbs0850       fbp     **−5.1**                                                    Hypothetical protein
  gbs1061               **4.1**                              I                      Hypothetical protein
  gbs1062               **3.8**                              I                      Hypothetical protein
  gbs1064               **2.3**                              I                      Hypothetical protein
  gbs1065               **2.6**                              I                      Hypothetical protein
  gbs1066               **3.5**                              I                      Hypothetical protein
  gbs1067               **3.2**                              I                      Hypothetical protein
  gbs1068               **3.2**                              I                     DNA segregation ATPase
  gbs1069               **5.7**                              I                      Hypothetical protein
  gbs1070               **5.1**     **3.9**     **5.7**      I                      Hypothetical protein
  gbs1071               **4.8**     **3.8**                  I                      Hypothetical protein
  gbs1072               **4.7**     **4.5**                  I                      Hypothetical protein
  gbs1073               **4.1**     **3.3**                  I                    Phage infection protein
  gbs1074               **4.6**     **4.8**                  I                      Hypothetical protein
  gbs1075               **4.9**     **7.5**     **3.9**      I                      Hypothetical protein
  gbs1076               **3.8**     **6.5**     **7.0**      I                      Hypothetical protein
  gbs1087               **3.5**     **3.0**                                         Hypothetical protein
  gbs1104               **−2.1**                                                          Antigen
  gbs1143       epf     **−3.0**   **−5.4**                                         Cell surface protein
  gbs1144                          **−2.3**    **−2.2**      C                      Cell surface protein
  gbs1234       neuD                            **2.7**      C             Sialic acid biosynthesis protein NeuD
  gbs1237.1     cpsL               **−2.2**                  C            beta-D-Galp alpha-2,3-sialyltransferase
  gbs1238      CpsIaJ              **−2.5**                  C          beta-D-GlcNAc beta-1,4-galactosyltransferase
  gbs1239       hasA               **−5.0**                  C      beta-D-Galp beta-1,3-N-acetylglucosaminyltransferase
  gbs1240       cpsI    **−2.5**   **−4.9**                  C               Secreted polysaccharide polymerase
  gbs1241       cpsG               **−3.2**                  C           beta-D-Glcp beta-1,4-galactosyltransferase
  gbs1242       cpsF               **−3.2**                  C        Beta-1,4-galactosyltransferase accessory protein
  gbs1248       cpsY               **−2.2**    **−2.5**      C            Transcriptional regulators, LysR family
  gbs1307       lmb                **−8.5**                                   Laminin-binding surface protein
  gbs1356                                       **8.1**                             Cell surface protein
  gbs1403               **8.1**                                                       5 -nucleotidase
  gbs1420               **−2.8**                                                  Choline-binding protein
  gbs1474               **−3.6**               **−2.6**                             Hypothetical protein
  gbs1475               **−4.8**                                                          Sortase
  gbs1477                                      **−10.1**                  Cell wall surface anchor family protein
  gbs1478               **−2.7**               **−5.1**                          Collagen adhesion protein
  gbs1492      rgpBc               **−15.1**                 B          alpha-L-Rha alpha-1,3-L-rhamnosyltransferase
  gbs1493      rgpAc               **−17.3**                 B        alpha-D-GlcNAc alpha-1,2-L-rhamnosyltransferase
  gbs1494       rmlD               **−9.2**                  B                dTDP-4-dehydrorhamnose reductase
  gbs1539                          **−5.2**    **−3.7**                             Hypothetical protein
  gbs1926                          **−2.6**                                   Laminin-binding surface protein
  gbs1929               **11.7**    **2.7**    **−3.1**                 2, 3 -cyclic-nucleotide 2 -phosphodiesterase
  gbs2000       cfa                 **3.2**                                             CAMP factor
  gbs2008      SpyCEP   **35.8**   **194.8**                                      Endopeptidase lactocepin

Values represent fold change in expression in amniotic fluid in comparison with expression in THY. ML, mid-logarithmic growth phase; LL, late-logarithmic growth phase; S, stationary growth phase. Cut-off: fold change above 2 and P value below 0.05; Classification of putative virulence genes in GBS (after Glaser, et al, 2002) H -- hemolysin, I -- pathogenicity island IX, C -- capsule, B -- group B antigen. Full list of changes is published as [Table S1](#pone.0006114.s001){ref-type="supplementary-material"}.

10.1371/journal.pone.0006114.t004

###### Selected genes involved in peptide and amino acid metabolism and transport differentially expressed in response to amniotic fluid.

![](pone.0006114.t004){#pone-0006114-t004-4}

  GBS        Locus      ML          LL           S                      Descriptions
  --------- ------- ---------- ------------ ----------- ---------------------------------------------
                                                                       **Peptidases**
  gbs0287    pepC    **3.0**     **4.9**      **5.9**          Aminopeptidase C (EC 3.4.22.40)
  gbs1021    pepN                 **−3**                       Aminopeptidase N (EC 3.4.11.15)
  gbs0779    pepF                **2.5**      **4.3**        Oligoendopeptidase F (EC 3.4.24.-)
  gbs1459    pepT                **−2.0**    **−3.7**           Tripeptidase T (EC 3.4.11.4)
  gbs1751                        **−3.8**    **−3.1**         Xaa-Pro dipeptidase (EC 3.4.13.9)
  gbs1781    pepXP               **2.7**                 Xaa-Pro dipeptidyl-peptidase (EC 3.4.14.11)
                                                                 **Oligopeptide transport**
  gbs0144    oppA    **2.4**     **2.6**      **3.5**            Oligopeptide-binding system
  gbs0145    oppB                **6.1**                        Oligopeptide transport system
  gbs0146    oppC                **8.0**                        Oligopeptide transport system
  gbs0147    oppD    **2.2**     **9.0**      **4.1**           Oligopeptide transport system
  gbs0148    oppF    **2.1**     **9.7**      **2.6**           Oligopeptide transport system
  gbs0966    oppA                **23.2**                     Oligopeptide-binding protein oppA
  gbs1513                        **−2.5**                        Di- tripeptide transporter
                                                               **Branched chains amino acids**
  gbs1627            **16.3**   **319.3**               
  gbs1628            **14.5**   **502.1**                         ATP-binding protein livF
  gbs1629            **17.7**   **146.5**                         ATP-binding protein livG
  gbs1630            **16.9**   **227.8**                           permease protein livM
  gbs1631            **19.7**    **94.9**                           permease protein livH
  gbs1632            **8.6**     **92.9**                              binding protein
  gbs1683    braB    **5.77**                                Branched-chain amino acid transport
  gbs2004                        **8.2**                
  gbs2005            **2.1**     **4.2**                
  gbs2006                        **5.4**                     Branched-chain amino acid transport
  gbs2007            **2.7**     **5.2**      **6.8**        Branched-chain amino acid transport
  gbs1610            **3.4**     **10.0**                              carrier protein
                                                                        **Arginine**
  gbs1077    carB    **6.0**     **7.3**                  Carbamoyl-phosphate synthase large chain
  gbs1078    carA    **6.3**     **7.5**                  Carbamoyl-phosphate synthase small chain
  gbs2122    arcA                **2.7**      **2.1**          Arginine deiminase (EC 3.5.3.6)
  gbs2123                                     **4.1**          Acetyltransferase (EC 2.3.1.-)
  gbs2124    arcB                             **5.3**    Ornithine carbamoyltransferase (EC 2.1.3.3)
  gbs2125     \-                              **5.5**           Arginine ornithine antiporter
  gbs2126    arcC                **−2.1**     **3.6**           Carbamate kinase (EC 2.7.2.2)
  gbs2083     \-     **−7.5**   **−140.4**   **−31.7**          Arginine ornithine antiporter
  gbs2084    arcC    **−3.6**   **−75.0**    **−43.6**                Carbamate kinase
  gbs2085    arcB    **−2.3**   **−28.8**    **−19.7**         Ornithine carbamoyltransferase

Values represent fold change in expression in amniotic fluid compared to expression in THY; ML, mid-logarithmic growth phase; LL, late-logarithmic growth phase; S, stationary growth phase; cut-off two fold change with P value less than 0.05. Positive values represent genes up-regulated in AF, negative values represent down-regulated (better expressed in THY) genes. Full list of changes is published as [Table S1](#pone.0006114.s001){ref-type="supplementary-material"}

10.1371/journal.pone.0006114.t005

###### Selected genes involved in nucleotide metabolism regulated in response to amniotic fluid.
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  GBS        Locus       ML         LL          S                                   Descriptions
  --------- -------- ---------- ----------- ---------- ----------------------------------------------------------------------
  gbs0014                        **−8.2**                          Hypoxanthine-guanine phosphoribosyltransferase
  gbs0017    prsA.2              **−6.1**    **−2.8**                    Ribose-phosphate pyrophosphokinase
  gbs0023      \-     **32.8**   **28.0**                     Phosphoribosylaminoimidazole-succinocarboxamide synthase
  gbs0024      \-     **38.9**   **56.1**                            Phosphoribosylformylglycinamidine synthase
  gbs0025     purF    **25.1**   **30.7**                                  Amidophosphoribosyltransferase
  gbs0026     purM    **25.6**   **31.8**    **5.4**               Phosphoribosylformylglycinamidine cyclo-ligase
  gbs0027     purN    **32.0**   **41.8**                           Phosphoribosylglycinamide formyltransferase
  gbs0028      \-     **21.0**   **26.8**    **9.1**                   Zwittermicin A resistance protein zmaR
  gbs0029     purH    **27.6**   **29.3**    **12.4**        Phosphoribosylaminoimidazolecarboxamide formyltransferase
  gbs0042     purD    **36.4**   **30.0**                                Phosphoribosylamine-glycine ligase
  gbs0043     purE    **49.0**   **47.5**               Phosphoribosylaminoimidazole carboxylase carboxyltransferase subunit
  gbs0044     purK    **34.9**   **27.2**                  Phosphoribosylaminoimidazole carboxylase NCAIR mutase subunit
  gbs0047     purB    **3.0**     **3.6**                                      Adenylosuccinate lyase
  gbs0106      \-                **−12.0**                                   CTP synthase (EC 6.3.4.2)
  gbs0553     pyrD    **6.5**     **3.5**    **7.1**                 Dihydroorotate dehydrogenase (EC 1.3.3.1)
  gbs0558                                    **−6.5**                         dGTP triphosphohydrolase
  gbs0574             **−7.3**                              Inosine-uridine preferring nucleoside hydrolase (EC 3.2.2.1)
  gbs0583             **4.4**                                                   Adenosine deaminase
  gbs0836    nrdF.2              **−3.2**                         Ribonucleoside-diphosphate reductase beta chain
  gbs0837    nrdE.2              **−3.3**                         Ribonucleoside-diphosphate reductase alpha chain
  gbs0844     udk                **−29.6**                                         Uridine kinase
  gbs1079     pyrB    **7.1**     **4.5**                                  Aspartate carbamoyltransferase
  gbs1080     pyrC    **3.7**     **3.6**                                          Dihydroorotase
  gbs1081     pyrE    **4.7**     **2.7**                                Orotate phosphoribosyltransferase
  gbs1082     pyrF    **5.6**     **2.3**    **3.9**                    Orotidine 5 -phosphate decarboxylase
  gbs1089    fhs.1    **3.1**     **4.1**                                 Formate-tetrahydrofolate ligase
  gbs1110      \-                **−5.0**                                         Thymidine kinase
  gbs1116                         **2.9**    **−2.6**                            Xanthine permease
  gbs1117     xpt                 **3.1**                                Xanthine phosphoribosyltransferase
  gbs1154     guaC    **2.4**     **8.8**                                          GMP reductase
  gbs1162      \-                **−6.0**    **4.1**                       GTP pyrophosphokinase homolog
  gbs1231     ung                **−2.7**                                      Uracil-DNA glycosylase
  gbs1867      \-                **−13.0**                                     Deoxyadenosine kinase
  gbs1929      \-     **11.7**    **2.7**    **−3.1**               2, 3 -cyclic-nucleotide 2 -phosphodiesterase

Values represent fold change in expression in amniotic fluid compared to expression in THY; ML, mid-logarithmic growth phase; LL, late-logarithmic growth phase; S, stationary growth phase; cut-off two fold change with P value less than 0.05. Positive values represent genes up-regulated in AF, negative values represent down-regulated (better expressed in THY) genes. Full list of changes is published as [Table S1](#pone.0006114.s001){ref-type="supplementary-material"}.

10.1371/journal.pone.0006114.t006

###### Selected genes involved in carbohydrate metabolism and transport differentially expressed in response to amniotic fluid.
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  Locus       Name       ML           LL           S                           Putative function
  --------- -------- ----------- ------------ ----------- ------------------------------------------------------------
  gbs0113             **−2.5**                  **9.5**                     D-ribose-binding protein
  gbs0114             **−2.3**     **2.1**      **9.7**          Ribose transport system permease protein rbsC
  gbs0115                          **2.7**      **5.7**            Ribose transport ATP-binding protein rbsA
  gbs0116                          **2.4**      **6.2**                       D-ribose mutarotase
  gbs0117                          **2.5**      **3.0**                            Ribokinase
  gbs0316      \-     **−3.4**     **10.8**                      PTS system, cellobiose-specific IIA component
  gbs0317      \-     **−3.1**     **5.5**     **18.2**          PTS system, cellobiose-specific IIB component
  gbs0318                          **4.3**                       PTS system, cellobiose-specific IIC component
  gbs0346     manN     **2.2**     **2.7**      **4.2**            PTS system, mannose-specific IID component
  gbs0347     manM                              **3.0**            PTS system, mannose-specific IIC component
  gbs0348     manL     **2.1**     **2.0**      **2.2**           PTS system, mannose-specific IIAB component
  gbs0872     glgC     **2.1**                             Glucose-1-phosphate adenylyltransferase catalytic subunit
  gbs0873      \-      **2.5**                             Glucose-1-phosphate adenylyltransferase regulatory subunit
  gbs1329     lacG                **−17.1**     **2.3**                   6-phospho-beta-galactosidase
  gbs1330     lacE                 **−8.1**                       PTS system, lactose-specific IIBC component
  gbs1331     lacF                **−11.7**                        PTS system, lactose-specific IIA component
  gbs1333    lacD.2               **−12.7**                              Tagatose-bisphosphate aldolase
  gbs1334    lacC.2   **−2.8**    **−18.7**                               Tagatose-6-phosphate kinase
  gbs1335    lacB.1   **−2.2**    **−10.2**     **3.9**           Galactose-6-phosphate isomerase lacB subunit
  gbs1336    lacA.2   **−2.1**    **−11.2**     **3.1**           Galactose-6-phosphate isomerase lacA subunit
  gbs1507     glgP    **−2.4**     **5.1**                                 Maltodextrin phosphorylase
  gbs1508     malM    **−2.9**     **5.9**                                 4-alpha-glucanotransferase
  gbs1510     malE                 **3.8**                            Maltose maltodextrin-binding protein
  gbs1511     malF                 **4.6**                    Maltodextrin transport system permease protein malC
  gbs1512     malG                 **3.5**                       Maltose transport system permease protein malG
  gbs1692             **−2.7**                                              Dihydroxyacetone kinase
  gbs1694             **−2.5**     **5.1**      **5.9**                     Dihydroxyacetone kinase
  gbs1695                          **3.9**      **8.4**                     Dihydroxyacetone kinase
  gbs1696                          **2.6**     **14.5**         Dihydroxyacetone kinase phosphotransfer protein
  gbs1697             **−2.4**     **2.5**     **11.8**               Glycerol uptake facilitator protein
  gbs1714                                       **3.9**                   Pyruvate,phosphate dikinase
  gbs1732     pmi                  **−3.2**                              Mannose-6-phosphate isomerase
  gbs1733     scrK    **−6.9**                                                    Fructokinase
  gbs1734     scrA    **−22.3**    **2.6**                        PTS system, sucrose-specific IIABC component
  gbs1735     scrB    **−5.2**                                           Sucrose-6-phosphate hydrolase
  gbs1777    glpF.2                **2.2**      **3.8**               Glycerol uptake facilitator protein
  gbs1797                          **−2.3**                        Galactose-1-phosphate uridylyltransferase
  gbs1811     plr      **2.1**     **2.5**                          Glyceraldehyde 3-phosphate dehydrogenase
  gbs1850      \-     **−2.5**     **−9.9**                                      Transaldolase
  gbs1893      \-     **−11.6**    **−6.5**                              2-dehydro-3-deoxygluconokinase
  gbs1911     dexB                 **2.9**                                Glucan 1,6-alpha-glucosidase
  gbs1912                                       **2.9**        Multiple sugar transport ATP-binding protein msmK
  gbs1914      \-     **−7.3**    **−169.1**                           Aldose 1-epimerase family protein
  gbs1915      \-     **−3.3**    **−61.2**    **−2.5**                  Tagatose-bisphosphate aldolase
  gbs1916      \-     **−3.1**    **−92.2**                               Tagatose-6-phosphate kinase
  gbs1917      \-     **−3.1**    **−67.0**                       Galactose-6-phosphate isomerase lacB subunit
  gbs1918    lacA.1   **−4.2**    **−296.9**                      Galactose-6-phosphate isomerase lacA subunit
  gbs1919                         **−14.8**                                  Sialidase A precursor
  gbs1920                         **−10.5**                       PTS system, galactose-specific IIC component
  gbs1921      \-     **−2.3**    **−14.4**                       PTS system, galactose-specific IIB component
  gbs1922      \-     **−3.6**    **−19.2**                       PTS system, galactose-specific IIA component
  gbs1923    lacR.1   **−2.7**     **−3.4**                       Lactose phosphotransferase system repressor
  gbs1936     ptsD                **−36.4**    **−10.1**       PTS system, mannose fructose family IID component
  gbs1937     ptsC                **−45.8**    **−31.4**       PTS system, mannose fructose family IIC component
  gbs1938     ptsB                **−37.6**    **−8.8**        PTS system, mannose fructose family IIB component
  gbs1939      \-     **−11.1**   **−34.6**    **−42.6**       PTS system, mannose fructose family IIA component
  gbs1946                          **5.8**      **4.6**           PTS system, glucose-specific IIABC component
  gbs2116      \-                  **−3.2**     **2.3**                  Glucose uptake family protein

Values represent fold change in expression in amniotic fluid compared to expression in THY; ML, mid-logarithmic growth phase; LL, late-logarithmic growth phase; S, stationary growth phase; cut-off two fold change with P value less than 0.05. Positive values represent genes up-regulated in AF, negative values represent down-regulated (better expressed in THY) genes. Full list of changes is published as [Table S1](#pone.0006114.s001){ref-type="supplementary-material"}

Stress response to AF {#s3c}
---------------------

We hypothesized that growth in amniotic fluid will trigger expression of genes involved in adaptation and the stress response. Although we observed changes in the transcript levels of multiple genes involved in adaptation, protein secretion and trafficking, and DNA repair, surprisingly, the transcripts were down regulated in response to growth in AF ([Table 1](#pone-0006114-t001){ref-type="table"}). The most striking examples are genes encoding putative cold shock protein (*gbs2053*, 55× down regulated in AF) or universal stress protein family (*gbs1778*, 27× down regulated in AF). However, we also observed moderate up-regulation of *groEL* and *clpL* transcripts. Thus, it appears that GBS does not exhibit a classic stress response when grown in AF, but rather readily adapts to this environment. We also did not observe massive down regulation of protein synthesis as an effect of stress, and interestingly, production of some ribosomal protein transcripts in LL and S phase was higher in AF than in THY ([Table S1](#pone.0006114.s001){ref-type="supplementary-material"}).

Regulatory events during growth in AF {#s3d}
-------------------------------------

The lack of alternative sigma factors in GBS [@pone.0006114-Glaser1] means that a successful regulatory response to environmental changes relies mainly on differential transcription of genes encoding two component systems (TCS) and stand-alone regulators. The GBS genome has genes encoding multiple TCS systems that might be involved in adaptation to various environments. As expected, we observed differential expression of multiple TCS and putative regulators of unknown function ([Table 2](#pone-0006114-t002){ref-type="table"}). One of the regulators with the greatest degree of transcriptional change encodes carbon starvation protein A ([Table 2](#pone-0006114-t002){ref-type="table"}). This change, together with observed alteration in transcripts of the genes encoding carbon catabolite proteins A and B might contribute to the large number of differential transcripts observed in genes encoding metabolic proteins (see below). In addition, we observed lowered expression of *codY*, a regulator involved predominantly in amino acid metabolism and activated by branched chain amino acids [@pone.0006114-Malke1]. In *Streptococcus pneumoniae* inactivation of *codY* gene is linked to decreased expression of *pcpA* adhesin and lower adhesion to human cells in vitro, suggesting possible mechanism linking metabolic state of the bacterium and pathogenic properties [@pone.0006114-Hendriksen1]. Recent analysis of *Streptococcus pyogenes* adaptation to blood found that a *codY* mutant strain strongly up-regulated expression of genes encoding branched chain amino acids transporters [@pone.0006114-Malke2], an observation consistent with differential expression of branched chain amino acid transporter genes we found in our experiment. Among differentially regulated TCSs we noted changes in expression of Gbs1671/1672 TCS, a homolog of the GAS CovR/S that is a major negative regulator of virulence genes in GBS and GAS [@pone.0006114-Lamy1], [@pone.0006114-Graham2]. We also observed differential expression of Gbs1397/1398, a TCS with ∼78% similarity to the GAS SptRS system (Spy874/875) required for survival in saliva and an important regulator of virulence and carbohydrate utilization GAS [@pone.0006114-Shelburne1], [@pone.0006114-Sitkiewicz2]. These GBS genes may regulate genes affecting carbohydrate metabolism.

Expression of virulence factors {#s3e}
-------------------------------

Compared to other pathogenic streptococci such as GAS, virulence factors of GBS are much less studied and therefore not well understood. However, we observed differential expression of multiple putative cell wall anchored proteins ([Table 3](#pone-0006114-t003){ref-type="table"}) and proven virulence factors. For example, the *cyl* operon, encoding a hemolysin, required for survival in blood and under oxidative stress [@pone.0006114-Liu1], [@pone.0006114-Nizet1] was up-regulated during growth in human AF. One of the more striking observations was very high up-regulation of the homolog of GAS SpyCEP (*gbs2008*). This extracellular protease cleaves and inactivates human interleukin 8 and contributes to virulence in GBS [@pone.0006114-Harris1] and GAS [@pone.0006114-Sumby1], [@pone.0006114-Edwards1]. In GAS, SpyCEP is greatly up-regulated in strains causing invasive infections compared to those recovered from patients with superficial infections such as pharyngitis [@pone.0006114-Edwards1]. We also detected an increased level of transcripts encoded by genes located in putative pathogenicity island IX (gbs1061-gbs1076), function of this element is unknown. Interestingly, transcripts of genes encoding multiple proteins implicated in adhesion to host molecules such as fibronectin, collagen, and laminin were significantly down-regulated during growth in AF. The C5a peptidase gene transcript also was significantly lower in GBS grown in AF, consistent with its involvement in fibronectin binding [@pone.0006114-Beckmann1]. Down-regulation of adhesins seems to be consistent with increased virulence. For example, molecular epidemiological data suggest a negative correlation between binding of fibronectin and severity of GAS infection [@pone.0006114-Natanson1]. Over-expression of fibronectin binding protein decreases the virulence of GAS lacking fibronectin binding protein gene resulted in reduced virulence and lack of fibronectin binding protein the surface promotes bacterial dissemination [@pone.0006114-Nyberg1].

Metabolism: Nutrient acquisition and energy production {#s3f}
------------------------------------------------------

GBS requires multiple exogenous compounds for growth, especially amino acids (AA). AF is composed mostly of water, urea, small amounts of amino acids, keratin from shed host epithelial cells, and proteins [@pone.0006114-vanScheltema1], [@pone.0006114-Mesavage1], [@pone.0006114-Cho1]. Thus, AF is relatively poor in nutrients, which means that bacteria with complex nutritional requirements will not grow or grow poorly. Unexpectedly, strain NEM316 grew very rapidly and to high cell density in AF ([Fig. 1](#pone-0006114-g001){ref-type="fig"}). We discovered that genes encoding systems that facilitate transport of amino acids and peptides were prominently up-regulated when GBS was grown in AF ([Figure 5AB](#pone-0006114-g005){ref-type="fig"}). In particular, multiple transport systems for branched-chain amino acids (isoleucine, leucine, valine) were very highly up-regulated, on the order of up to 500× more highly expressed during growth in THY ([Table 4](#pone-0006114-t004){ref-type="table"}). Recently Samen and co-workers [@pone.0006114-Samen1] showed that growth of GBS in AF depends on intact isoleucine and oligopeptide transport systems. Because GBS is auxotrophic towards multiple amino acids, presumably the up-regulation of amino acid transport systems is a direct result of an effort to scavenge these molecules. Oligopeptide transport systems in group A and B streptococci has been also shown to be involved in pathogenic properties as adhesion [@pone.0006114-Samen1], [@pone.0006114-Darmstadt1]. Recently, increasing number of reports links ability to utilize nutrients and metabolic state of the bacterium with its pathogenic properties [@pone.0006114-Shelburne2], [@pone.0006114-Loughman1]. Therefore, similar to carbohydrates, amino acid and oligopeptide transport and utilization processes might play a role in pathogenicity of GBS.

We also observed significant differential expression of genes in the arginine deiminase pathway. Arginine fermentation can be used for energy production by GAS, and likely GBS [@pone.0006114-Pine1]. The genome of GBS strain NEM316 has two putative sets of genes involved in this metabolic pathway. However, it has not been confirmed experimentally if both of them are indeed involved in arginine deiminase pathway. Locus 1 (with high homology to GAS) is up regulated in response to AF, locus 2 with lower homology to GAS genes is down regulated in response to AF. Arginine deiminase seems to have a profound effect on streptococcal biology and virulence. We recently described regulation of arginine deiminase by growth phase [@pone.0006114-Sitkiewicz1] in GBS, and a similar phenomenon was also described recently for *Streptococcus gordonii* [@pone.0006114-Liu2]. Arginine deiminase also influences expression of fimbriae in *Porphyromonas gingivalis* [@pone.0006114-Lin1]. In GAS, arginine utilization is under control of major regulators *rgg* [@pone.0006114-Chaussee1] and *ccpA* [@pone.0006114-Shelburne2] and arginine deiminase is a potent inhibitor of human T-cell proliferation [@pone.0006114-Degnan1]. Moreover, despite the fact that it lacks export signal sequence, arginine deiminase is found on the GAS cell surface [@pone.0006114-Lei1] and is a protective antigen in mice \[A. Henningham, M.R Batzloff, J.C. Cole, C.M. Gillen, J. Hartas, K. S. Sriprakash, M. J. Walker, poster nr. P54, 2008 Lancefield International Symposium on Streptococci & Streptococcal Diseases, Porto Heli, Greece\].

Additionally, arginine metabolism is linked to nucleotide metabolism by carbamoyl phosphate. The *carAB* genes encoding subunits of carbamoyl phosphate synthase are also differentially regulated in GBS grown in AF. We observed significant up regulation of gene transcripts for almost all enzymes involved in *de novo* purine and pyrimidine synthesis and down regulation of salvage pathways ([Table 5](#pone-0006114-t005){ref-type="table"}). This was especially prominent in the early stages of growth, suggesting that AF lacks sufficient free nucleotides for rapid growth.

Carbohydrate metabolism {#s3g}
-----------------------

Among genes involved in carbohydrate utilization in GBS, large portion is constituted by multiple transport systems (mostly PTS) that allow uptake of various carbohydrate sources. We detected differential expression of many genes involved in carbohydrate transport and metabolism ([Table 6](#pone-0006114-t006){ref-type="table"}) ([Fig. 5B](#pone-0006114-g005){ref-type="fig"}). Interestingly, GBS rather down-regulated genes responsible for the transport of simple carbohydrates what suggests their low concentration in AF.

Summary {#s3h}
-------

We have discovered that GBS significantly remodels its transcriptome in response to exposure to human amniotic fluid. A large number of the affected genes are of unknown function, which means that much remains to be learned about the full influence of amniotic fluid on GBS. The majority of the observed changes in transcripts affects genes involved in basic bacterial metabolism and is connected to AF composition and nutritional requirements of the bacterium. The observation that many genes encoding adhesions are down-regulated, and genes encoding known virulence factors such as a hemolysin and a potent IL-8 proteinase are up-regulated likely have consequences for the outcome of host-pathogen interactions.

Supporting Information {#s4}
======================
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Changes in transcription of GBS genes upon contact with amniotic fluid. All changes detected in transcription of GBS in response to amniotic fluid Values represent fold change in expression in amniotic fluid compared to expression in THY; ML, mid-logarithmic growth phase; LL, late-logarithmic growth phase; S, stationary growth phase; cut-off two fold change with P value less than 0.05. Positive values represent genes up-regulated in AF, negative values represent down-regulated (better expressed in THY) genes.
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